Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout

Editas Medicine, Inc. EDIT Stock Forecast

AI-powered price prediction and analysis for Editas Medicine, Inc. ยท Updated Apr 17, 2026

AI 90-Day Forecast
HOLD
7 Days
โ–ˆโ–ˆ%
30 Days
โ–ˆโ–ˆ%
90 Days
โ–ˆโ–ˆ%
April 17, 2026

See EDIT's Exact Price Target

Create a free account to unlock AI predictions for 4,000+ stocks

Sign Up Free with Google
โœ“ Free account ยท โœ“ 30-day trial ยท โœ“ Cancel anytime

Price Chart

Loading chart...

Key Statistics

Market Cap
$342M
P/B Ratio
12.52x
ROE
-260.1%
Revenue
$40M
Current Ratio
3.54x
D/E Ratio
5.84x

About Editas Medicine, Inc.

Editas Medicine, Inc. (EDIT) operates in the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. .

Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Life Sciences Biological Products, (No Diagnostic Substances) Nasdaq Small Cap

Latest News

Biological Products, (No Diagnostic Substances) Peers

Company Ticker AI Signal Market Cap P/E
Acumen Pharmaceuticals, Inc. ABOS โ–ˆโ–ˆ% $204M -x
Abpro Holdings, Inc. ABP โ–ˆโ–ˆ% $310K -x
Abpro Holdings, Inc. ABPO โ–ˆโ–ˆ% $880K -x
Arcellx, Inc. ACLX โ–ˆโ–ˆ% $6.66B -x
Alpha Cognition Inc. ACOG โ–ˆโ–ˆ% $151M -x
Adaptimmune Therapeutics Plc ADAP โ–ˆโ–ˆ% $77M -13.2x
Adma Biologics, Inc. ADMA โ–ˆโ–ˆ% $2.62B 17.8x
Adaptive Biotechnologies Corp ADPT โ–ˆโ–ˆ% $2.23B -x
Adverum Biotechnologies, Inc. ADVM โ–ˆโ–ˆ% $95M -1.8x
Agenus Inc AGEN โ–ˆโ–ˆ% $169M 1471.2x
Agentix Corp. AGTX โ–ˆโ–ˆ% $2M -x
Aim Immunotech Inc. AIM โ–ˆโ–ˆ% $4M -x
Aim Immunotech Inc. AIMI โ–ˆโ–ˆ% $1M -x
Alector, Inc. ALEC โ–ˆโ–ˆ% $284M -x
Aligos Therapeutics, Inc. ALGS โ–ˆโ–ˆ% $41M -x
Allogene Therapeutics, Inc. ALLO โ–ˆโ–ˆ% $792M -x
Alvotech ALVO โ–ˆโ–ˆ% $1.13B -x
Amgen Inc AMGN โ–ˆโ–ˆ% $191.44B 24.8x
Apogee Therapeutics, Inc. APGE โ–ˆโ–ˆ% $6.31B -x
Aptose Biosciences Inc. APTOF โ–ˆโ–ˆ% $4M -x
Argenx Se ARGX โ–ˆโ–ˆ% $52.54B -x
Armata Pharmaceuticals, Inc. ARMP โ–ˆโ–ˆ% $421M -x
Artiva Biotherapeutics, Inc. ARTV โ–ˆโ–ˆ% $307M -x
Leonabio, Inc. ATHA โ–ˆโ–ˆ% $23M -0.2x
Atara Biotherapeutics, Inc. ATRA โ–ˆโ–ˆ% $43M 1.3x
Atyr Pharma Inc ATYR โ–ˆโ–ˆ% $84M -x
Aura Biosciences, Inc. AURA โ–ˆโ–ˆ% $464M -x
Autolus Therapeutics Plc AUTL โ–ˆโ–ˆ% $426M -x
Anavex Life Sciences โ€ฆ AVXL โ–ˆโ–ˆ% $337M -x
Bioatla, Inc. BCAB โ–ˆโ–ˆ% $8M -x
Biocardia, Inc. BCDA โ–ˆโ–ˆ% $13M -x
Brainstorm Cell Therapeutics โ€ฆ BCLI โ–ˆโ–ˆ% $10M -x
Biocryst Pharmaceuticals Inc BCRX โ–ˆโ–ˆ% $2.38B 9.0x
Black Diamond Therapeutics, โ€ฆ BDTX โ–ˆโ–ˆ% $175M 7.8x
Beam Therapeutics Inc. BEAM โ–ˆโ–ˆ% $3.19B -x
Biogen Inc. BIIB โ–ˆโ–ˆ% $26.03B 20.1x
Biontech Se BNTX โ–ˆโ–ˆ% $26.03B -x
Cabaletta Bio, Inc. CABA โ–ˆโ–ˆ% $346M -x
Candel Therapeutics, Inc. CADL โ–ˆโ–ˆ% $467M -x
C4 Therapeutics, Inc. CCCC โ–ˆโ–ˆ% $283M -x
Cidara Therapeutics, Inc. CDTX โ–ˆโ–ˆ% $6.49B -1.0x
Creative Medical Technology โ€ฆ CELZ โ–ˆโ–ˆ% $9M -x
Cero Therapeutics Holdings, โ€ฆ CERO โ–ˆโ–ˆ% $1M -x
Cullinan Therapeutics, Inc. CGEM โ–ˆโ–ˆ% $907M -x
Compugen Ltd CGEN โ–ˆโ–ˆ% $267M 3.8x
Cg Oncology, Inc. CGON โ–ˆโ–ˆ% $5.92B -x
Cognition Therapeutics Inc CGTX โ–ˆโ–ˆ% $106M -x
Coherus Oncology, Inc. CHRS โ–ˆโ–ˆ% $297M 1.8x
Calidi Biotherapeutics, Inc. CLDI โ–ˆโ–ˆ% $3M -x
Cellectis S.A. CLLS โ–ˆโ–ˆ% $456M -x
Compass Therapeutics, Inc. CMPX โ–ˆโ–ˆ% $1.07B -x
Mosaic Immunoengineering Inc. CPMV โ–ˆโ–ˆ% $5M -x
Caribou Biosciences, Inc. CRBU โ–ˆโ–ˆ% $142M -1.5x
Cardiff Oncology, Inc. CRDF โ–ˆโ–ˆ% $123M -x
Cardiol Therapeutics Inc. CRDL โ–ˆโ–ˆ% $169M -x
Curis Inc CRIS โ–ˆโ–ˆ% $24M -x
Crispr Therapeutics Ag CRSP โ–ˆโ–ˆ% $5.56B -x
Champions Oncology, Inc. CSBR โ–ˆโ–ˆ% $84M -x
Cel Sci Corp CVM โ–ˆโ–ˆ% $42M -x
Dbv Technologies S.A. DBVT โ–ˆโ–ˆ% $1.26B -x
Dbv Technologies S.A. DBVTF โ–ˆโ–ˆ% $10K -x
Ginkgo Bioworks Holdings, โ€ฆ DNA โ–ˆโ–ˆ% $467M -x
Denali Therapeutics Inc. DNLI โ–ˆโ–ˆ% $3.21B -x
Precision Biosciences Inc DTIL โ–ˆโ–ˆ% $190M -x
Dyadic International Inc DYAI โ–ˆโ–ˆ% $32M -x
Editas Medicine, Inc. EDIT โ–ˆโ–ˆ% $342M -x
Eloxx Pharmaceuticals, Inc. ELOX โ–ˆโ–ˆ% $560K -x
Elutia Inc. ELUT โ–ˆโ–ˆ% $48M 0.9x
Engene Therapeutics Inc. ENGN โ–ˆโ–ˆ% $541M -x
Entera Bio Ltd. ENTX โ–ˆโ–ˆ% $70M -x
Viskase Holdings, Inc. ENZN โ–ˆโ–ˆ% $4M -x
Estrella Immunopharma, Inc. ESLA โ–ˆโ–ˆ% $80M -x
Evaxion A/S EVAX โ–ˆโ–ˆ% $37M -x
Exelixis, Inc. EXEL โ–ˆโ–ˆ% $11.78B 15.1x
Exozymes Inc. EXOZ โ–ˆโ–ˆ% $89M -x
Fate Therapeutics Inc FATE โ–ˆโ–ˆ% $160M -x
4d Molecular Therapeutics, โ€ฆ FDMT โ–ˆโ–ˆ% $536M -x
Fennec Pharmaceuticals Inc. FENC โ–ˆโ–ˆ% $232M -x
Finch Therapeutics Group, โ€ฆ FNCH โ–ˆโ–ˆ% $12M 0.5x
Finch Therapeutics Group, โ€ฆ FNCHQ โ–ˆโ–ˆ% $12M 0.5x
Futuretech Ii Acquisition โ€ฆ FTII โ–ˆโ–ˆ% $52M -x
Futuretech Ii Acquisition โ€ฆ FTIIU โ–ˆโ–ˆ% $14M -x
Gilead Sciences, Inc. GILD โ–ˆโ–ˆ% $170.81B 20.1x
Monte Rosa Therapeutics, โ€ฆ GLUE โ–ˆโ–ˆ% $1.58B -x
Genenta Science S.P.A. GNTA โ–ˆโ–ˆ% $17M -x
Green Planet Bio โ€ฆ GPLB โ–ˆโ–ˆ% $340K -x
Greenland Mines Ltd GRML โ–ˆโ–ˆ% $51M -x
Halozyme Therapeutics, Inc. HALO โ–ˆโ–ˆ% $8.16B 25.8x
Humacyte, Inc. HUMA โ–ˆโ–ˆ% $158M -x
Immunitybio, Inc. IBRX โ–ˆโ–ˆ% $7.79B -x
Inhibikase Therapeutics, Inc. IKT โ–ˆโ–ˆ% $242M -x
Imagenebio, Inc. IMA โ–ˆโ–ˆ% $66M -x
Immunocore Holdings Plc IMCR โ–ˆโ–ˆ% $1.59B -x
Immatics N.V. IMTX โ–ˆโ–ˆ% $1.50B -x
Immunovant, Inc. IMVT โ–ˆโ–ˆ% $5.96B -x
In8bio, Inc. INAB โ–ˆโ–ˆ% $14M -x
Inhibrx Biosciences, Inc. INBX โ–ˆโ–ˆ% $873M -6.8x
Mink Therapeutics, Inc. INKT โ–ˆโ–ˆ% $71M -x
Inmune Bio, Inc. INMB โ–ˆโ–ˆ% $39M -x
Intensity Therapeutics, Inc. INTS โ–ˆโ–ˆ% $13M -x
Iovance Biotherapeutics, Inc. IOVA โ–ˆโ–ˆ% $1.59B -x
Century Therapeutics, Inc. IPSC โ–ˆโ–ˆ% $467M -x
Invivyd, Inc. IVVD โ–ˆโ–ˆ% $491M -x
Jasper Therapeutics, Inc. JSPR โ–ˆโ–ˆ% $29M -x
Kalaris Therapeutics, Inc. KLRS โ–ˆโ–ˆ% $145M -x
Klotho Neurosciences, Inc. KLTO โ–ˆโ–ˆ% $56M -x
Kodiak Sciences Inc. KOD โ–ˆโ–ˆ% $2.77B -x
Krystal Biotech, Inc. KRYS โ–ˆโ–ˆ% $8.00B 39.1x
Kymera Therapeutics, Inc. KYMR โ–ˆโ–ˆ% $7.13B -x
Kyverna Therapeutics, Inc. KYTX โ–ˆโ–ˆ% $600M -x
Ladrx Corp LADX โ–ˆโ–ˆ% $20K -x
Lineage Cell Therapeutics, โ€ฆ LCTX โ–ˆโ–ˆ% $416M -x
Lenz Therapeutics, Inc. LENZ โ–ˆโ–ˆ% $319M -x
Liminatus Pharma, Inc. LIMN โ–ˆโ–ˆ% $10M -x
Leonabio, Inc. LONA โ–ˆโ–ˆ% $83M -x
Lexeo Therapeutics, Inc. LXEO โ–ˆโ–ˆ% $504M -x
Maze Therapeutics, Inc. MAZE โ–ˆโ–ˆ% $1.39B -x
Mesoblast Ltd MESO โ–ˆโ–ˆ% $2.15B -x
Meiragtx Holdings Plc MGTX โ–ˆโ–ˆ% $937M -x
Metagenomi Therapeutics, Inc. MGX โ–ˆโ–ˆ% $56M -x
Molecular Partners Ag MOLN โ–ˆโ–ˆ% $170M -x
Moderna, Inc. MRNA โ–ˆโ–ˆ% $21.17B -x
Neurocrine Biosciences Inc NBIX โ–ˆโ–ˆ% $13.34B 27.9x
Nkgen Biotech, Inc. NKGN โ–ˆโ–ˆ% $2M -0.1x
Neumora Therapeutics, Inc. NMRA โ–ˆโ–ˆ% $375M -x
Novavax Inc NVAX โ–ˆโ–ˆ% $1.44B 3.3x
Ocugen, Inc. OCGN โ–ˆโ–ˆ% $622M -x
Outlook Therapeutics, Inc. OTLK โ–ˆโ–ˆ% $32M -x
Palisade Bio, Inc. PALI โ–ˆโ–ˆ% $402M -x
Passage Bio, Inc. PASG โ–ˆโ–ˆ% $37M -x
Vaxcyte, Inc. PCVX โ–ˆโ–ˆ% $8.17B -x
Biomx Inc. PHGE โ–ˆโ–ˆ% $16M -x
Pluri Inc. PLUR โ–ˆโ–ˆ% $36M -x
Protalix Biotherapeutics, Inc. PLX โ–ˆโ–ˆ% $187M -x
Pharmacyte Biotech, Inc. PMCB โ–ˆโ–ˆ% $8M -x
Prime Medicine, Inc. PRME โ–ˆโ–ˆ% $688M -x
Prokidney Corp. PROK โ–ˆโ–ˆ% $657M -x
Pelthos Therapeutics Inc. PTHS โ–ˆโ–ˆ% $74M -x
Qiagen N.V. QGEN โ–ˆโ–ˆ% $8.95B -x
Quince Therapeutics, Inc. QNCX โ–ˆโ–ˆ% $22M -x
Qrons Inc. QRON โ–ˆโ–ˆ% $150K -x
Replimune Group, Inc. REPL โ–ˆโ–ˆ% $173M -x
Repligen Corp RGEN โ–ˆโ–ˆ% $7.39B 151.2x
Regenxbio Inc. RGNX โ–ˆโ–ˆ% $483M -x
Relay Therapeutics, Inc. RLAY โ–ˆโ–ˆ% $2.91B -x
Revolution Medicines, Inc. RVMD โ–ˆโ–ˆ% $29.28B -x
Recursion Pharmaceuticals, Inc. RXRX โ–ˆโ–ˆ% $2.00B -x
Sab Biotherapeutics, Inc. SABS โ–ˆโ–ˆ% $271M 20.4x
Sana Biotechnology, Inc. SANA โ–ˆโ–ˆ% $939M -x
Scilex Holding Co SCLX โ–ˆโ–ˆ% $49M -x
Scinai Immunotherapeutics Ltd. SCNI โ–ˆโ–ˆ% $2M -x
Sangamo Therapeutics, Inc SGMO โ–ˆโ–ˆ% $108M -x
Solid Biosciences Inc. SLDB โ–ˆโ–ˆ% $849M -x
Silexion Therapeutics Corp SLXN โ–ˆโ–ˆ% $4M -x
Senti Biosciences, Inc. SNTI โ–ˆโ–ˆ% $34M -x
Scholar Rock Holding โ€ฆ SRRK โ–ˆโ–ˆ% $5.42B -x
Surrozen, Inc./De SRZN โ–ˆโ–ˆ% $371M -x
Sutro Biopharma, Inc. STRO โ–ˆโ–ˆ% $523M -x
Protara Therapeutics, Inc. TARA โ–ˆโ–ˆ% $292M -x
Tarsus Pharmaceuticals, Inc. TARS โ–ˆโ–ˆ% $2.86B -x
Tc Biopharm (Holdings) โ€ฆ TCBPY โ–ˆโ–ˆ% $10K -x
Tscan Therapeutics, Inc. TCRX โ–ˆโ–ˆ% $68M -x
Bio-Techne Corp TECH โ–ˆโ–ˆ% $9.23B 113.8x
Tectonic Therapeutic, Inc. TECX โ–ˆโ–ˆ% $553M -x
Instil Bio, Inc. TIL โ–ˆโ–ˆ% $60M -x
Tenaya Therapeutics, Inc. TNYA โ–ˆโ–ˆ% $170M -x
Tourmaline Bio, Inc. TRML โ–ˆโ–ˆ% $1.23B -3.5x
Taysha Gene Therapies, โ€ฆ TSHA โ–ˆโ–ˆ% $1.79B -x
Titan Pharmaceuticals Inc TTNP โ–ˆโ–ˆ% $6M -0.5x
Tevogen Bio Holdings โ€ฆ TVGN โ–ˆโ–ˆ% $31M -x
Twist Bioscience Corp TWST โ–ˆโ–ˆ% $3.73B -x
Voyager Acquisition Corp./Cayman โ€ฆ VACH โ–ˆโ–ˆ% $416M 46.3x
Voyager Acquisition Corp./Cayman โ€ฆ VACHU โ–ˆโ–ˆ% $68M 6.7x
Valneva Se VALN โ–ˆโ–ˆ% $543M -x
Vericel Corp VCEL โ–ˆโ–ˆ% $1.80B 109.2x
Vir Biotechnology, Inc. VIR โ–ˆโ–ˆ% $1.71B -x
Vivosim Labs, Inc. VIVS โ–ˆโ–ˆ% $4M -x
Vor Biopharma Inc. VOR โ–ˆโ–ˆ% $785M -x
Vaxart, Inc. VXRT โ–ˆโ–ˆ% $180M 11.0x
Voyager Therapeutics, Inc. VYGR โ–ˆโ–ˆ% $242M -x
Windtree Therapeutics Inc โ€ฆ WINT โ–ˆโ–ˆ% $490K -x
X4 Pharmaceuticals, Inc XFOR โ–ˆโ–ˆ% $385M -x
Zeo Scientifix, Inc. ZEOX โ–ˆโ–ˆ% $16M -x
Zivo Bioscience, Inc. ZIVO โ–ˆโ–ˆ% $8M -x
Zura Bio Ltd ZURA โ–ˆโ–ˆ% $543M -x

FAQ

  • Is Editas Medicine, Inc. a good stock to buy?

    Our AI analyzes Editas Medicine, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.

  • How accurate are Editas Medicine, Inc. predictions?

    Our AI achieves a 8500% Spearman correlation for this stock, with 67%+ average accuracy across 4,000+ stocks analyzed daily.

  • How often are forecasts updated?

    Editas Medicine, Inc. forecasts are updated daily using the latest market data and AI models.

Ready to invest smarter?

Join thousands of investors using AI-powered stock predictions

Sign Up Free
โœ“ Free account ยท โœ“ 4,000+ stocks ยท โœ“ Daily updates

Looking for a deeper analysis of Editas Medicine, Inc.?

View full institutional-grade analysis on Intratio โ†’

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.

My Portfolio

Investment Dashboard

Loading your portfolio...